Unit 4-Antiarrhythmics Flashcards
Quinidine, procainamide, disopyramide
Drug class
Class IA anti-arrhythmics
Quinidine, procainamide, disopyramide
Mechanism
Block inward potassium rectifying channel (slow rate) at normal concentrations; blocks sodium channels (fast rate) at high concentrations
Quinidine, procainamide, disopyramide
Uses
Atrial fibrillation/flutter, paroxsymal supraventricular tachycardia, ventricular tachycardia
Quinidine, procainamide, disopyramide
Side effects
QT prolongation; TdP arrhythmias; heart block; hypotension; lupus-like syndrome
GI symptoms; cinchonism, hepatitis, & thrombocytopenia w/ quinidine; anticholinergic effects w/ disopyramide
Lidocaine, mexiletine
Drug class
Class IB anti-arrhythmics
Lidocaine, mexiletine
Mechanism
Block sodium channels in inactivated state mostly; no action on atrial tissue
Lidocaine, mexiletine
Uses
Digitalis toxicity
Lidocaine, mexiletine
Side effects
Tremor; nausea; seizures; local anesthetic action
GI toxicity w/ mexiletine
Flecainide, propafenone, moricizine
Drug class
Class IC anti-arrhythmics
Flecainide, propafenone, moricizine
Mechanism
Sodium channel blockers (most potent in class I), acting as negative ionotrope
Flecainide, propafenone, moricizine
Uses
Atrial fibrillation/flutter, paroxsymal supraventricular tachycardia, ventricular tachycardia
Flecainide, propafenone, moricizine
Side effects
Worsened heart failure, proarrhythmia in ischemic tissue, increased mortality
Blurred vision w/ flecainide; sinus bradycardia & brochospasm w/ propafenone
Propanolol, carvedilol.
Drug class
Class II anti-arrhythmics - beta blockers (non-selective)
Propanolol, carvedilol
Mechanism
Blocks beta-adrenergic receptors; decrease SA, AV node activity (phase 4 depolarization)
Propanolol, carvedilol.
Uses
Control of ventricular rate in atrial fibrillation/flutter; long-term suppression of SVTs; PVCsControl of ventricular rate in atrial fibrillation/flutter; long-term suppression of SVTs; PVCs